KELAPROFEN 100 MG/ML, SOLUTION FOR INJECTION FOR CATTLE, HORSES AND PIGS

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

KETOPROFEN

Pieejams no:

Kela n.v.

ATĶ kods:

QM01AE03

SNN (starptautisko nepatentēto nosaukumu):

KETOPROFEN

Deva:

100 Mg/Ml

Zāļu forma:

Solution for Injection

Receptes veids:

POM

Ārstniecības grupa:

Bovine, Equine - Food, Porcine

Ārstniecības joma:

Ketoprofen

Ārstēšanas norādes:

N.S.A.I.D

Autorizācija statuss:

Authorised

Autorizācija datums:

2012-02-24

Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Kelaprofen 100 mg/ml, solution for injection for cattle, horses and
pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Per ml
ACTIVE SUBSTANCE:
Ketoprofen 100 mg
EXCIPIENTS:
Benzyl alcohol (E1519) 10 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection
Clear, colourless or yellowish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, cattle, pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Horse
-
the alleviation of inflammation and pain associated with
musculoskeletal disorders;
-
the alleviation of visceral pain associated with colic.
Cattle
-
the supportive treatment of parturient paresis associated with
calving;
-
reducing the pyrexia and distress associated with bacterial
respiratory disease when used in conjunction with
antimicrobial therapy as appropriate;
-
improving the recovery rate in acute clinical
mastitis,
including acute endotoxin mastitis,
caused by Gram-
negative micro-organisms, in conjunction with antimicrobial therapy;
-
reducing oedema of the udder associated with calving.
Pigs
-
reducing the pyrexia and respiratory rate associated with bacterial
or viral
respiratory disease when used in
conjunction with antimicrobial therapy as appropriate;
-
the supportive treatment
of Mastitis Metritis Agalactia Syndrome in sows,
in conjunction with antimicrobial
therapy as appropriate.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_